Interferon alpha and rapamycin inhibit the growth of pheochromocytoma PC12 line in vitro | Zendy

Ewelina Motylewska | Zendy; Hanna Ławnicka | Zendy; Magdalena KowalewiczKulbat | Zendy; Paulina Sicińska | Zendy; Agata Niedziela | Zendy; Gabriela Mełeń-Mucha | Zendy; H Stępień | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Interferon alpha and rapamycin inhibit the growth of pheochromocytoma PC12 line in vitro

Author(s) -

Ewelina Motylewska,

Hanna Ławnicka,

Magdalena KowalewiczKulbat,

Paulina Sicińska,

Agata Niedziela,

Gabriela Mełeń-Mucha,

H Stępień

Publication year - 2013

Publication title -

endokrynologia polska

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.413

H-Index - 27

eISSN - 2299-8306

pISSN - 0423-104X

DOI - 10.5603/ep.2013.0020

Subject(s) - pheochromocytoma , medicine , alpha interferon , endocrinology , interferon , immunology

Pheochromocytomas are benign or malignant neuroendocrine tumours. The unsatisfactory efficacy of the traditional therapeutic methods for patients with metastatic disease results in a continuing search for more effective and targeted agents. Due to the increased vascularisation of these tumours, inhibitors of angiogenesis could be potentially a new group of drugs in pheochromocytoma/paraganglioma therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research